Cargando…
Can Aliskiren be Considered as a New Novel Drug for Hypertension?
Hypertension is one of the most common causes of death across the globe. Many trials and drugs have been used for controlling the debilitating effects of hypertension. One such new class of drug is direct renin inhibitors (DRI), e.g., aliskiren, which block the renin-angiotensin system (RAS). It blo...
Autores principales: | Bhatti, Adnan Bashir, Gazali, Zarine Anwar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671838/ https://www.ncbi.nlm.nih.gov/pubmed/26677425 http://dx.doi.org/10.7759/cureus.375 |
Ejemplares similares
-
Recent Advances and Review on Treatment of Stiff Person Syndrome in Adults and Pediatric Patients
por: Bhatti, Adnan Bashir, et al.
Publicado: (2015) -
Relationship of Hypertensive Retinopathy with Mean Platelet Volume Among Hypertensive Patients
por: Bhatti, Adnan Bashir, et al.
Publicado: (2015) -
Drug Targets for Oxidative Podocyte Injury in Diabetic Nephropathy
por: Bhatti, Adnan Bashir, et al.
Publicado: (2015) -
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
por: Sureshkumar, Kalathil K
Publicado: (2008) -
Correlation Between Body Mass Index and Blood Pressure Levels Among Hypertensive Patients: A Gender-Based Comparison
por: Khalid, Faran, et al.
Publicado: (2020)